A new drug called cannabidiol (CBD) is on the market in China, and many users in the country have reported using it for relief from severe depression.CBD, or cannabigerol, is a non-psychoactive component of cannabis that is sometimes used as an appetite stimulant and pain relief.
The DEA recently classified CBD as a Schedule 1 controlled substance.
According to a report from China’s state-run Xinhua News Agency, some people have reported finding relief from depression after taking CBD.
The report claims to have received information from the Shanghai Medical Association about several people who used CBD for relief of their severe depression, which has been in remission for three months.
Xinhua reports that the Shanghai Med Association said that it has been receiving reports from people who have used CBD products.
“There are many people who use CBD as an anti depression medicine and the majority of them have been in treatment for depression,” said a Shanghai Med official, adding that he was unable to confirm if these people were Chinese citizens.
A report from the Chinese Medical Association also noted that people who are taking CBD products should follow the government’s recommendations.
According the Chinese Association, people who abuse drugs should be given medical assistance.
It added that CBD should be prescribed in combination with other therapies and medication.
While some have reported that CBD has been effective for depression, others have expressed concern about how it will be administered.
A study from the University of Washington in Seattle published in March 2017 found that CBD had no significant effect on depressive symptoms or quality of life in depressed people.
However, other studies have found that cannabinoids may affect mood and cognition in people with depression.
In a study published in the American Journal of Psychiatry, researchers found that people taking CBD had worse quality of sleep and less activity during the first few days of their symptoms.
Other studies have shown that CBD can interfere with the body’s ability to produce the brain chemical serotonin.
While CBD can be used to treat anxiety and depression, there are concerns that it could also have potential for addiction.
A 2014 study published by the National Institutes of Health found that using CBD could increase the risk of substance abuse.
The study found that participants who used the drug had higher levels of the brain chemicals dopamine and norepinephrine, two chemicals that are released in the brain as a response to stress.
According a study by the Center for Addiction and Mental Health (CAMH), more than half of people who tested positive for cannabis use during the study used it for a substance other than marijuana.
A 2012 study published online by the Journal of Psychopharmacology found that cannabis use may increase the severity of psychosis, anxiety and PTSD symptoms.
“The results suggest that cannabis is a potential neuropsychopharmacologic trigger of psychosis in some individuals,” the study found.
“This is a new area of research and a novel finding, and we must wait to confirm these findings before prescribing cannabis to treat psychosis.”